Impact of the COVID-19 pandemic on lung cancer diagnoses and mortality: A nationwide study in France
The lower incidence observed during the first wave with no catch-up in the following periods could be explained by deaths among yet undiagnosed patients, either from COVID-19 or as a result of barriers to accessing healthcare. The excess mortality observed for both operated and non-operated patients may be attributable to delayed diagnosis, as well as to COVID-19-related deaths.
Authors
- Jonas Poucineau (ORCID: https://orcid.org/0000-0003-0017-4919)
- C. Chouaïd (ORCID: https://orcid.org/0000-0002-4290-5524)
- Myriam Khlat (ORCID: https://orcid.org/0000-0002-6674-3718)
- Sophie Le Cœur (ORCID: https://orcid.org/0000-0001-6952-9234)
- Maude Espagnacq
- Nathanaël Lapidus (ORCID: https://orcid.org/0000-0002-4837-1068)
- Tristan Delory (ORCID: https://orcid.org/0000-0002-0165-8934)
Institutions
- Institut national d'études démographiques (FR)
- Inserm (FR)
- Sorbonne Université (FR)
- Sorbonne Paris Cité (FR)
- Institut de Recherche et de Documentation en Économie de la Santé (FR)
- Hôpital Saint-Antoine (FR)
- National Institute for Demographic Studies (FR)
- Centre Hospitalier Annecy Genevois (FR)
- Institut Pierre Louis d‘Épidémiologie et de Santé Publique (FR)
- Hôpital Intercommunal de Créteil (FR)
- Institut Mondor de Recherche Biomédicale (FR)
- Établissement public Campus Condorcet (FR)
Publication Details
- Journal
- Cancer Epidemiology
- Published
- 2024-10-10
- DOI
- https://doi.org/10.1016/j.canep.2024.102679
- Citations
- 1
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- Ministère des Solidarités et de la Santé